Gharagozlian Sedegheh, Henriksen Tore, Kolset Svein Olav
Dept. of Nutrition Institute of Basic Medical Sciences, University of Oslo, Box 1046, Blindern, 0316 Oslo, Norway.
Eur J Nutr. 2006 Aug;45(5):283-90. doi: 10.1007/s00394-006-0597-8. Epub 2006 May 16.
Hyperglycaemia may contribute to endothelial dysfunction. Disturbances in endothelial functions include changes in the extracellular matrix underneath the cells. This may result from altered biosynthesis of matrix molecules or from modified biosynthesis and secretion of enzymes involved in the turnover of extracellular matrix. One important class of such enzymes are the matrix metalloproteinases (MMPs).
The aim of this study was to investigate whether the condition of high glucose concentration relevant both to diabetes type 1 and 2 and metabolic syndrome, would affect the synthesis and release of MMPs in human umbilical cord endothelial cells (HUVEC) in vitro.
The HUVEC were isolated and cultured in vitro. The cells were exposed to medium with either low glucose (LG, 1 g/l) or high glucose (HG, 4.5 g/l) or the advanced glycation end product (AGE) N(epsilon)-(carboxymethyl) lysine bovine serum albumin (CML-BSA), at a concentration of 10 microg/ml. The HUVEC-conditioned media were harvested and subjected to gelatin zymography and Western blotting.
When HUVEC were incubated with HG or CML-BSA under serum free conditions a decreased secretion of pro MMP-2 was observed, both with gelatin zymography and Western blotting. The HUVEC also secreted MMP-9, but at lower levels, and effects of HG treatment were not significant. When HUVEC were stimulated with phorbol 12-myristate 13-acetate (PMA) secretion of pro MMP-2 was not increased, but the activation of pro MMP-2 into lower molecular forms increased, irrespective of culturing in LG, HG or CML-BSA.
The HUVEC exposed to high glucose or AGE exhibit decreased secretion of MMP-2. These findings may be relevant in understanding the altered turnover of the endothelial extracellular matrix observed in the diabetic state.
高血糖可能导致内皮功能障碍。内皮功能紊乱包括细胞下方细胞外基质的变化。这可能是由于基质分子生物合成改变,或参与细胞外基质周转的酶的生物合成和分泌改变所致。这类酶的一个重要类别是基质金属蛋白酶(MMPs)。
本研究旨在探讨与1型和2型糖尿病以及代谢综合征相关的高葡萄糖浓度状况,是否会在体外影响人脐静脉内皮细胞(HUVEC)中MMPs的合成与释放。
分离并体外培养HUVEC。将细胞暴露于含低葡萄糖(LG,1 g/l)或高葡萄糖(HG,4.5 g/l)的培养基中,或浓度为10 μg/ml的晚期糖基化终产物(AGE)N(ε)-(羧甲基)赖氨酸牛血清白蛋白(CML-BSA)中。收集HUVEC条件培养基,进行明胶酶谱分析和蛋白质印迹分析。
在无血清条件下,当HUVEC与HG或CML-BSA孵育时,通过明胶酶谱分析和蛋白质印迹分析均观察到前MMP-2分泌减少。HUVEC也分泌MMP-9,但水平较低,HG处理的影响不显著。当用佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)刺激HUVEC时,前MMP-2的分泌未增加,但前MMP-2激活为较低分子形式增加,无论在LG、HG或CML-BSA中培养。
暴露于高葡萄糖或AGE的HUVEC表现出MMP-2分泌减少。这些发现可能有助于理解糖尿病状态下观察到的内皮细胞外基质周转改变。